Anne W. Schmidt

5.1k citations

70 papers · 3.9k indexed · h-index 35

Impact in

Behavioral Neuroscience top 1%
- Stress Responses and Cortisol
Biological Psychiatry top 1%
- Tryptophan and brain disorders

Papers in

Biological Psychiatry 4
Cellular and Molecular Neuroscience 27
- Neurotransmitter Receptor Influence on Behavior 11
- Neuropeptides and Animal Physiology 10
- Neuroscience and Neuropharmacology Research 8

Co-authors: Stevin H. Zorn Stephen J. Peroutka James Heym Hans Rollema Jeffrey Sprouse Stafford McLean Lorraine A. Lebel David W. Schulz
Journals: Journal of Medicinal Chemistry (15 papers)European Journal of Pharmacology (9 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Child and Adolescent Social Work Journal (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
Partner nations: United States Netherlands Germany

In The Last Decade

Anne W. Schmidt

69 papers receiving 3.7k citations

Peers

Countries citing papers authored by Anne W. Schmidt

Since Specialization

Citations

This map shows the geographic impact of Anne W. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne W. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne W. Schmidt more than expected).

Fields of papers citing papers by Anne W. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne W. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne W. Schmidt. The network helps show where Anne W. Schmidt may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne W. Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne W. Schmidt Line = papers co-authored together Anne W. Schmidt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Affinity and Potency of RTH258 (ESBA1008), a Novel Inhibitor of Vascular Endothelial Growth Factor A for the Treatment of Retinal Disorders Investigative Ophthalmology & Visual Science ·Dominika Czechová, Gunther Spohn, G. M. Schmid, Mohammad Irafn, Dia Khadam Al Jamé, Patrik Maurer, Anne W. Schmidt, Dominik Escher	2015	35
2	An Updated Midline Rule: Visual Callosal Connections Anticipate Shape and Motion in Ongoing Activity across the Hemispheres Journal of Neuroscience ·Chung Soo Chun, M.R Ortiz Acosta, David Eriksson, Anne W. Schmidt, Kerstin Schmidt	2013	9
3	Pharmacological Characterization of 2-Methyl-N-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a High-Affinity Antagonist Selective for κ-Opioid Receptors Journal of Pharmacology and Experimental Therapeutics ·S. Grimwood, Yang Lü, Anne W. Schmidt, Michelle Vanase‐Frawley, Aarti Sawant‐Basak, Emily Miller, Stafford McLean, John Freeman, Stephen T.C. Wong, Jay P. McLaughlin, Patrick R. Verhoest	2011	52
4	Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1). Journal of Medicinal Chemistry ·Patrick R. Verhoest, Douglas S. Chapin, Michael L. Corman, Kari R. Fonseca, John F. Harms, Xinjun Hou, Eric S. Marr, Frank S. Menniti, Frederick Nelson, Rebecca E. O’Connor, Jayvardhan Pandit, Agisni Fatihaturrohmah, Anne W. Schmidt, Christopher J. Schmidt, Arman Zan, Spiros Liras	2009	172
5	Quantitative structure–activity relationship of phenoxyphenyl-methanamine compounds with 5HT2A, SERT, and hERG activities Bioorganic & Medicinal Chemistry Letters ·Scot Mente, Randall J. Gallaschun, Anne W. Schmidt, Choygan Sanchai, Michelle Vanase‐Frawley, Anton Fliri	2008	7
6	Antagonism of 5‐HT_1Areceptors uncovers an excitatory effect of SSRIs on 5‐HT neuronal activity, an action probably mediated by 5‐HT₇receptors Journal of Neurochemistry ·Fokko J. Bosker, Joost H.A. Folgering, Anatoliy V. Gladkevich, Anne W. Schmidt, Anne Dilani Schrøder, Jeffrey Sprouse, Johan A. den Boer, Ben H.C. Westerink, Thomas I.F.H. Cremers	2008	28
7	Assay Concordance between SPA and TR-FRET in High-Throughput Screening SLAS DISCOVERY ·Oliver von Ahsen, Anne W. Schmidt, Vladimir Achourov, Karsten Parczyk	2006	27
8	The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release European Journal of Pharmacology ·David E. Johnson, Frank M. Nedza, Douglas K. Spracklin, Karen Ward, Anne W. Schmidt, Philip A. Iredale, D. W. Potter, Hans Rollema	2004	32
9	Cultivation of HEK 293 cell line and production of a member of the superfamily of G-protein coupled receptors for drug discovery applications using a highly efficient novel bioreactor Cytotechnology ·Marian Merritt, Gabriela Borrayo Sánchez, Anne W. Schmidt, Liang Huang	2004	24
10	Serotonin‐induced phase advances of SCN neuronal firing in vitro: A possible role for 5‐HT_5A receptors? Synapse ·Jeffrey Sprouse, Linda Reynolds, John P. Braselton, Anne W. Schmidt	2004	33
11	Discovery of a series of (4,5-Dihydroimidazol-2-yl)-biphenylamine 5-HT7 agonists Bioorganic & Medicinal Chemistry Letters ·Vinod D. Parikh, Willard M. Welch, Anne W. Schmidt	2003	23
12	The Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review CNS Drug Reviews ·Patricia A. Seymour, Anne W. Schmidt, David W. Schulz	2003	87
13	Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain European Journal of Pharmacology ·David E. Johnson, Hans Rollema, Anne W. Schmidt, Aileen McHarg	2001	38
14	5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex Biological Psychiatry ·Hans Rollema, Yi Lu, Anne W. Schmidt, Jeffrey Sprouse, Stevin H. Zorn	2000	165
15	CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor Regulatory Peptides ·Stafford McLean, R. Michael Snider, Manoj C. Desai, Terry Rosen, Dianne K. Bryce, Kelly P. Longo, Anne W. Schmidt, James Heym	1993	29
16	Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin Journal of Medicinal Chemistry ·John E. Macor, C. Clamageran, Carol B. Fox, Janko Pejovic, B. Kenneth Koe, Lorraine A. Lebel, Jean Morrone, Kevin Ryan, Anne W. Schmidt	1992	14
17	The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels European Journal of Pharmacology ·Anne W. Schmidt, Stafford McLean, James Heym	1992	145
18	Sertraline potently displaces (+)-[3H]3-PPP binding to σ sites in rat brain European Journal of Pharmacology ·Anne W. Schmidt, Lorraine A. Lebel, B. Kenneth Koe, Thomas Seeger, James Heym	1989	50
19	Antidepressant interactions with 5-hydroxytryptamine3 receptor binding sites European Journal of Pharmacology ·Anne W. Schmidt, Stephen J. Peroutka	1989	24
20	The psychological dimensions of infertility. American Journal of Orthopsychiatry ·S. T. Hall, Joseph Palombo, 芳史富岡, Joyce Mattos, Steven A. Meyers, Anne W. Schmidt	1980	91

About Anne W. Schmidt

Anne W. Schmidt is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience, Behavioral Neuroscience, Psychiatry and Mental health and Organic Chemistry, having authored 70 papers that have together received 3.9k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (24 papers), Neurotransmitter Receptor Influence on Behavior (11 papers), Neuropeptides and Animal Physiology (10 papers), Pharmacological Receptor Mechanisms and Effects (8 papers), Neuroscience and Neuropharmacology Research (8 papers), Synthesis and Biological Evaluation (5 papers), Hormonal Regulation and Hypertension (5 papers) and Stress Responses and Cortisol (5 papers). The work is most often cited by research in Behavioral Neuroscience (512 citations), Biological Psychiatry (294 citations), Cellular and Molecular Neuroscience (1.7k citations), Psychiatry and Mental health (661 citations) and Molecular Biology (1.6k citations). Anne W. Schmidt has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Stevin H. Zorn, Stephen J. Peroutka, James Heym, Hans Rollema, Jeffrey Sprouse, Stafford McLean, Lorraine A. Lebel, David W. Schulz, Harry Howard and Yi Lu. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Pharmacology, Bioorganic & Medicinal Chemistry Letters, Child and Adolescent Social Work Journal and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact